123 related articles for article (PubMed ID: 22261802)
1. HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis.
Pan B; Ren H; He Y; Lv X; Ma Y; Li J; Huang L; Yu B; Kong J; Niu C; Zhang Y; Sun WB; Zheng L
Clin Cancer Res; 2012 Mar; 18(5):1246-56. PubMed ID: 22261802
[TBL] [Abstract][Full Text] [Related]
2. Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis.
Pan B; Ren H; Lv X; Zhao Y; Yu B; He Y; Ma Y; Niu C; Kong J; Yu F; Sun WB; Zhang Y; Willard B; Zheng L
J Transl Med; 2012 Mar; 10():65. PubMed ID: 22462581
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation.
Huang X; He D; Ming J; He Y; Zhou C; Ren H; He X; Wang C; Jin J; Ji L; Willard B; Pan B; Zheng L
Breast Cancer Res Treat; 2016 Feb; 155(3):441-55. PubMed ID: 26872904
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.
Pan B; Ren H; Ma Y; Liu D; Yu B; Ji L; Pan L; Li J; Yang L; Lv X; Shen X; Chen B; Zhang Y; Willard B; He Y; Zheng L
Int J Cancer; 2012 Jul; 131(1):70-82. PubMed ID: 21805479
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
6. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
7. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
[TBL] [Abstract][Full Text] [Related]
8. Nonenzymatic glycation of high-density lipoprotein impairs its anti-inflammatory effects in innate immunity.
Liu D; Ji L; Zhang D; Tong X; Pan B; Liu P; Zhang Y; Huang Y; Su J; Willard B; Zheng L
Diabetes Metab Res Rev; 2012 Feb; 28(2):186-95. PubMed ID: 21928330
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
11. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
[TBL] [Abstract][Full Text] [Related]
12. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
13. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy.
Sorrentino SA; Besler C; Rohrer L; Meyer M; Heinrich K; Bahlmann FH; Mueller M; Horváth T; Doerries C; Heinemann M; Flemmer S; Markowski A; Manes C; Bahr MJ; Haller H; von Eckardstein A; Drexler H; Landmesser U
Circulation; 2010 Jan; 121(1):110-22. PubMed ID: 20026785
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
Tan M; Yao J; Yu D
Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
[TBL] [Abstract][Full Text] [Related]
15. Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.
Cai W; Ye L; Sun J; Mansel RE; Jiang WG
Int J Mol Med; 2010 Apr; 25(4):573-80. PubMed ID: 20198306
[TBL] [Abstract][Full Text] [Related]
16. Cis-polyunsaturated fatty acids stimulate beta1 integrin-mediated adhesion of human breast carcinoma cells to type IV collagen by activating protein kinases C-epsilon and -mu.
Palmantier R; George MD; Akiyama SK; Wolber FM; Olden K; Roberts JD
Cancer Res; 2001 Mar; 61(6):2445-52. PubMed ID: 11289113
[TBL] [Abstract][Full Text] [Related]
17. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
18. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3681-9. PubMed ID: 14666664
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of bone sialoprotein silencing on the adhesion ability of breast cancer cells to bone matrix].
Wang L; Wang J; Yang D; Yang C; Xia B; Wang J; Xian J
Sheng Wu Gong Cheng Xue Bao; 2011 Feb; 27(2):233-9. PubMed ID: 21650048
[TBL] [Abstract][Full Text] [Related]
20. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
